In October 2020, eLife announced the appointment of Diane Harper, MD, MPH (University of Michigan) and Mone Zaidi, MD, PhD, FRCP (Icahn School of Medicine at Mount Sinai) as Deputy Editors for eLife to lead the journal’s expansion into medical research and explore new approaches for peer review and publishing. Since then eLife has been recruiting new Senior and Reviewing Editors who are specialists in different areas of translational, clinical and public health research. So far, as part of this effort, 11 new Senior Editors and more than 50 new Reviewing Editors have joined the journal.
Our newest Senior Editors include:
- Ricardo Azziz, MD (State University of New York at Albany and University of Alabama at Birmingham) – Women's Health, Endocrinology, Public Health, Social Determinants of Health, Health Policy
- Balram Bhargava, MD (Indian Council of Medical Research) – Cardiovascular Medicine, Epidemiology and Public Health
- Nancy Carrasco, MD (Vanderbilt University) – Endocrinology
- Betty Diamond, MD (The Feinstein Institute for Medical Research) – Immunology, Inflammation, and Rheumatology
- Wafik El-Deiry, MD, PhD (Brown University) – Oncology
- Carlos Isales, MD (Augusta University) – Endocrinology, Geriatrics, Regenerative Medicine
- Dennis Lo, DPhil, DM (The Chinese University of Hong Kong) – Clinical Genetics, Pathology
- Paul Noble, MD (Cedars–Sinai Medical Center) – Pulmonary Medicine
- Martin Pollak, MD (Harvard University) – Clinical Genetics, Nephrology
- David Serwadda, MB, ChB, MPH (Makerere University) – Epidemiology and Public Health, Infectious Diseases
- Ma-Li Wong, MD, PhD (State University of New York Upstate Medical University) – Psychiatry, Translational Neuroscience
"I was very excited to join the team at eLife and contribute to making science communication more constructive, collaborative, transparent and more easily accessible to all", says new Senior Editor David Serwadda of Makerere University School of Public Health. "In the areas of infectious disease and public health research", he adds, "I have been seeing outstanding work being submitted in HIV, COVID-19, malaria, genomics and disease modelling. I look forward to working with the team to expand the topical and geographical scope further to make eLife a home for important global research on other underrepresented conditions that affect populations."
The enthusiasm is echoed by Ricardo Azziz, who joined the editorial team as a Senior Editor in October 2021: "Given the public health challenges we face, with inequalities to care and treatment at a global scale, eLife's mission to provide thoughtful and collaborative reviews for significant findings in this space is a breath of fresh air in medical publishing. I am honoured to be part of a team that really sees the value of translating discoveries into real-world applications that can improve people's lives."
The new Senior Editors will work alongside eLife's existing team of Senior Editors for medical research, including the two Deputy Editors:
- Matthias Barton, MD (University of Zurich) – Cardiovascular Medicine
- Christian Büchel, MD (University Medical Center Hamburg–Eppendorf) – Neurology
- Jeannie Chin, PhD (Baylor College of Medicine) – Translational Neuroscience, Neurology
- Miles Davenport, MB, BS, DPhil (University of New South Wales) – Epidemiology and Public Health, Infectious Diseases, Immunology
- Eduardo Franco, MPH, DrPH (McGill University) – Epidemiology and Public Health, Oncology, Women's Health
- Wendy Garrett, MD, PhD (Harvard University) – Oncology, Immunology
- Diane Harper, MD, MPH (University of Michigan) – Epidemiology and Public Health, Women's Health, Family Medicine
- Jos van der Meer, MD, PhD (Radboud University Nijmegen Medical Centre) – Immunology, Infectious Diseases
- Gary Westbrook, MD, PhD (Oregon Health & Science University) – Translational Neuroscience, Neurology
- Richard White, MD, PhD (Memorial Sloan Kettering Cancer Center) – Oncology
- Mone Zaidi, MD, PhD, FRCP (Icahn School of Medicine at Mount Sinai) – Endocrinology, Metabolism, Internal Medicine, Regenerative Medicine
The number of Reviewing Editors handling submissions in medicine for eLife has also more than doubled with the addition of 58 new members to our Board of Reviewing Editors over the past months:
- Yousef Abu-Amer, PhD (Washington University School of Medicine in St Louis) – Orthopedics, Rheumatology, Inflammation
- David Allison, PhD (Indiana University) – Endocrinology, Nutrition, Clinical Genetics
- Wadih Arap, MD, PhD (Rutgers Cancer Institute of New Jersey) – Oncology
- Hossein Ardehali, MD, PhD (Northwestern University) – Cardiovascular Medicine
- Mohammad Athar, PhD (University of Alabama at Birmingham) – Dermatology
- Narayan Avadhani, PhD (University of Pennsylvania) – Mitochondrial Diseases
- Audrey Bernstein, PhD (State University of New York Upstate Medical University) – Ophthalmology, Regenerative Medicine
- Marc Bonten, MD (University Medical Center Utrecht) – Infectious Diseases, Epidemiology and Public Health
- Philip Boonstra, PhD (University of Michigan) – Biostatistics, Epidemiology and Public Health
- Christoph Buettner, MD (Rutgers Robert Wood Johnson Medical School) – Endocrinology, Metabolism
- Murim Choi, PhD (Seoul National University College of Medicine) – Clinical Genetics, Bioinformatics
- Jennifer Cullen, PhD, MPH (Case Western Reserve University) – Epidemiology and Public Health
- Rajan Dighe, PhD (Indian Institute of Science Bangalore) – Endocrinology, Biologics
- Hannelore Ehrenreich, MD (Max Planck Institute of Experimental Medicine) – Neurology, Psychiatry
- Elana Fertig, PhD (Johns Hopkins University) – Cancer Genetics, Bioinformatics
- Edward Fisher, MD, PhD (New York University) – Cardiovascular Medicine
- Maria Grano, PhD (University of Bari) – Endocrinology, Bone Diseases
- Yelena Ginzburg, MD (Icahn School of Medicine at Mount Sinai) – Hematology, Oncology
- Sang Jun Han, PhD (Baylor College of Medicine) – Reproductive Health
- Christopher Huang, MD, PhD (University of Cambridge) – Muscle Diseases, Cardiovascular Medicine
- Jameel Iqbal, MD, PhD (Icahn School of Medicine at Mount Sinai) – Pathology
- Gérard Karsenty, MD, PhD (Columbia University) – Genetics, Metabolism, Bone Biology
- Brian Kim, MD (Washington University School of Medicine in St Louis) – Dermatology, Immunology
- T Rajendra Kumar, PhD (University of Colorado) – Reproductive Health, Endocrinology
- Gabriel Leung, MD (University of Hong Kong) – Epidemiology and Public Health, Health Policy, Health Systems, Infectious Diseases
- Hongliang Li, MD, PhD (Wuhan University) – Hepatology, Cardiovascular Medicine
- Paloma Liton, PhD (Duke University) – Ophthalmology, Pathology
- Caigang Liu, PhD (Shengjing Hospital, China Medical University) – Oncology, Surgery
- Elham Mahmoudi, PhD (University of Michigan) – Health Economics, Health Services Research, Social Determinants of Health
- Gillian McLellan, BVMS, PhD (University of Wisconsin–Madison) – Ophthalmology
- Simón Méndez-Ferrer, PhD (University of Cambridge) – Hematology, Regenerative Medicine, Stem Cell Biology
- Tomohiro Morio, MD, PhD (Tokyo Medical and Dental University) – Pediatrics, Immunology
- Nicola Napoli, MD, PhD (University of Rome) – Endocrinology
- Goutham Narla, MD, PhD (University of Michigan) – Clinical Genetics, Oncology, Drug Repurposing
- Tony Ng, MD (King's College London) – Oncology
- Jérémie Nsengimana, PhD (Newcastle University) – Biostatistics, Epidemiology and Public Health
- Renata Pasqualini, PhD (Rutgers Cancer Institute of New Jersey) – Cancer Biology, Radiation Oncology
- David Paterson, DPhil (University of Oxford) – Cardiovascular Medicine, Organ Physiology
- Matthew Quinn, PhD (Wake Forest School of Medicine) – Pathology, Endocrinology, Liver Diseases
- Jalees Rehman, MD (University of Illinois at Chicago) – Pharmacology, Regenerative Medicine
- Albert Rizvanov, PhD (Kazan Federal University) – Regenerative Medicine, Stem Cell biology
- Gian Paolo Rossi, MD (University of Padua) – Cardiovascular Medicine, Endocrinology
- Maroeska Rovers, PhD (Radboud University) – Health Services Research, Health Systems, Health Economics, Social Determinants of Health
- Mishaela Rubin, MD (Columbia University) – Endocrinology
- Fayaz Safadi, PhD (Northeast Ohio Medical University) – Regenerative Medicine, Biomechanics, Bioengineering
- Ernestina Schipani, MD, PhD (University of Pennsylvania) – Orthopedics, Surgery
- Nicolas Schlecht, PhD (Roswell Park Comprehensive Cancer Center) – Epidemiology and Public Health, Oncology
- Hiroshi Takayanagi, MD, PhD (University of Tokyo) – Immunology, Orthopedic Surgery
- Sakae Tanaka, MD (University of Tokyo) – Orthopedics, Surgery
- Ritu Trivedi, PhD (CSIR–Central Drug Research Institute) – Endocrinology
- Samra Turajlic, MBBS, PhD (The Francis Crick Institute) – Oncology
- Farah Usmani, MD (United Nations Population Fund (UNFPA)) – Health Policy, Reproductive Health, Women's Health
- Ignatia Van den Veyver, MD (Baylor College of Medicine) – Clinical Genetics, Reproductive Health
- Mei Wan, PhD (Johns Hopkins University) – Orthopedic Surgery, Bone Biology
- Christopher Williams, MD, PhD (Vanderbilt University) – Gastroenterology
- Tony Yuen, PhD (Icahn School of Medicine at Mount Sinai) – Clinical Genetics
- Shengtao Zhou, MD (Sichuan University) – Oncology, Women's Health
- Bian Zhuan, DMD (Wuhan University) – Dentistry and Oral Medicine
The expansion of eLife's team in medicine will continue in the future as new developments in research focused on understanding and improving human health arise.
"I am truly excited to see the remarkable progress during this year in reinvigorating eLife’s medical sciences portfolio. This is reflected in both the quality and breadth of submissions we have received”, says eLife Deputy Editor Mone Zaidi. "There are areas where we want to expand even further, such as regenerative medicine, bioengineering, cancer therapeutics, metabolism, diagnostic imaging, cardiovascular medicine and infectious diseases".
eLife Deputy Editor Diane Harper adds: "It is my ambition to further grow eLife's presence in advancing scientific transparency in the triple aim of enhancing patient experience, improving population health, and reducing costs through translational research completed through clinical and community-based trials, population registries, and linked database analyses. These rigorous scientific methods and results can be promoted through the eLife process quite effectively! It has been a rewarding experience to build this team and get the chance to work with so many bright and energetic researchers committed to addressing important medical challenges of our time."
In addition to topical coverage, eLife's editorial board will continue to embrace the interdisciplinary richness of translational medicine and look to evaluate new discoveries and applications ranging from early clinical studies to population-level research and implementation. In eLife's Medicine section, we are looking to publish significant translational research and clinical studies focused on improving human health. Our interests include, but are not limited to, the etiology, pathophysiology, diagnosis, genetics, prevention, and treatment of human disorders, as well as the biological, environmental and socioeconomic determinants of health which lead to changes in medical practice, population health and health policy. Some examples include a recent study on a dataset to track the excess mortality of the COVID-19 pandemic and research on biomarker panels for clinical use that could improve triage and risk prediction in Dengue patients.
A full list of the editors who handle medicine for eLife is available here:
https://elifesciences.org/about/people/medicine
eLife articles in medicine are available here:
https://elifesciences.org/subjects/medicine
#
Questions and comments are welcome. Please annotate publicly on the article or contact us at hello [at] elifesciences [dot] org.
For the latest updates and other news from eLife, sign up to receive our bi-monthly newsletter. You can also follow @eLife on Twitter.
